---
artifact_id: adv-S-3.01a-pass-14
review_target: S-3.01a-tmux-control-mode
producer: adversary
pass: 14
fresh_context: true
branch: feature/S-3.01a-tmux-control-mode
base: develop @ 609c6ae
tip: 5e54aa4
findings_count: 0
findings_by_severity: {critical: 0, high: 0, medium: 0, low: 0, nitpick: 0}
verdict: CONVERGED
timestamp: 2026-06-26
note: Returned inline by adversary because tool profile is read-only; persisted by orchestrator via state-manager.
---

# Adversarial Review — Pass 14 — S-3.01a

## Critical Findings
None.

## High Findings
None.

## Medium Findings
None.

## Low Findings
None.

## Nitpicks
None.

## Verification Notes

Fresh-context review against the perimeter found no real defects. Exercised:

- **Spec-implementation conformance:** ARCH-09 classifications (boundary/effectful) match; ARCH-08 §6.6 import constraints honored (session imports admission only; tmux imports halfchannel+session); ADR-010 `tmux -C` flag honored.
- **Concurrency:** Close → wg.Wait synchronization, sync.Once guards on errCh/frames, mu-protected lifecycle fields, no internal-pointer leak from session.ListSessions/Get.
- **Lifecycle hazards:** subprocess reap via cmd.Wait goroutine; pipe cleanup on Connect failure paths; idempotent Publish/Unpublish on protocol replay; single-use semantics (closed flag + ErrControlModeClosed).
- **Error paths:** all error returns checked; ST1005-compliant strings; errors.Is/As used; sentinel errors documented.
- **Backpressure:** frames channel non-blocking send under spec-permitted ~1% drop budget (AC-004).
- **Test hermeticism:** all tests inject fake execFn; no real-tmux dependency.

Real-tmux protocol detail (%session-created $N session-id vs name) is explicitly deferred via VP-031 → integration harness (Task 8, S-3.01a v1.1). Not a finding.

## Self-Validation

Three iterations performed. Each candidate concern (Close-race, subprocess leak, send-on-closed-channel race, internal-pointer leak, ADR-vs-BC -C/-CC text, real-tmux protocol parsing) was traced to a corresponding mitigation or documented deferral. No candidate survived to finding-grade evidence.

## Novelty Assessment

Novelty: LOW — second consecutive clean pass after extensive defect-discovery curve (passes 1-12). Implementation has reached steady state.

## Streak status

Pass 13: CONVERGED (0)
Pass 14: CONVERGED (0)

**Streak: 2/3 toward BC-5.39.001.**
